Citi Downgrades Raptor Pharmaceuticals (RPTP) to Neutral

August 8, 2016 9:34 AM EDT
Get Alerts RPTP Hot Sheet
Price: $9.00 --0%

Rating Summary:
    7 Buy, 6 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 19 | Down: 33 | New: 11
Trade RPTP Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Citi earlier downgraded Raptor Pharmaceuticals (NASDAQ: RPTP) from Buy to Neutral.

For an analyst ratings summary and ratings history on Raptor Pharmaceuticals click here. For more ratings news on Raptor Pharmaceuticals click here.

Shares of Raptor Pharmaceuticals closed at $6.89 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Related Entities

Citi

Add Your Comment